The Accuracy of Detecting Diabetic Retinopathy Using Panoptic Ophthalmoscope by Primary Care Doctors At Klinik Kesihatan Sendayan

Nur Aishah Abdul Latiff, Nor Nadiah Ishak, Mohd Amin Fauzi, Maznun Mat Jidin, Mastura Ismail

Abstract


Diabetic Retinopathy (DR) is a microvascular complications of diabetes that may lead to blindness. The prevalence is increasing which demands early detection to prevent further deterioration of retinopathy. However, the gold standard fundus camera is not widely available in primary care. This study assesses the accuracy of PanOptic Opthalmoscope (PO) as a screening tool for DR at primary care level. A cross-sectional study on 66 diabetes patients were enrolled via systematic random sampling. Sample size was calculated using PASS software and OpenEpi method. PO and fundus camera were done on the same day with DR screening. PO were done among six primary care doctors. Fundus camera photo was interpreted by the Ophthalmologist as gold standard. Both findings were compared and analysed. PO has low accuracy (53%) in detecting DR.The sensitivity and specificity of  DR detection was 10.3 % and 86.5% respectively. The positive predictive value (PPV) was 37.5% and negative predictive value (NPV) was 55.2%. The accuracy of Sight threatening abnormalities (STA) was 75.8%. The sensitivity and specificity of STA were 35.3% and 89.8%, respectively. The PPV was 54.4% and NPV was 80%. The prevalence of newly diagnosed DR was 43.9%, while prevalence of STA was 25.8%. DR is significantly associated with patients living with diabetes for more than 10 years (p = 0.007). The accuracy of PO in DR screening is poor, but it is modestly acceptable for STA detection. However, the sensitivity and PPV is low, causing some serious retinopathy cases undetected. The prevalence of DR is higher with increasing duration of diabetes. We recommend the availability of fundus camera in primary care setting.

Keywords


medical

Full Text:

PDF

References


World Health Organization (WHO), Fact Sheets: Diabetes. 2018

National Institute of Health (NIH) Malaysia. The National Health and morbidity survey (NHMS) NCDs-Non-Communicable Diseases: Risk factors and other health problems. National Institute of Health.Selangor. 2019.

National Institute of Health (NIH) Malaysia. The Thirds National Health and morbidity survey (NHMS III) 2006.

Ministry of Health (MOH) Malaysia Diabetic Retinopathy Screening Team. Diabetic retinopathy screening, Training module for healthcare providers. Second edition. Ministry of Health Malaysia. 2017.

Clinical Practice Guidelines (CPG) secretariat. Screening of Diabetic Retinopathy. Putrajaya: Medical Development Division; 2011.

Clinical Practice guidelines (CPG) secretariat, Management of Type 2 Diabetes Mellitus. 5th Edition.Putrajaya: Medical Development Division; 2015.

Pin GP, Salowi MA, Adnan TH, Sa’at N, The 8th Report of the National Eye Database 2014. National Eye Database(NED); Selangor, 2016.

National Diabetes Registry (NDR) Report 2020, Disease Control Division, Ministry of Health Malaysia. Putrajaya.

Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR. Vision Loss Expert Group. Causes of vision loss worldwide,1990-2010: A systematic analysis. Lancet Glob Health. 2013.

Zhang X, Low S, Kumari N, Wang J, Ang K, Yeo D, et al. Direct medical cost associated with diabetic retinopathy severity in Type 2 Diabetes in Singapore.2017

Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012.

Zhang P, Zhang X, Brown JB, Vistisen D, Sicree RA, Shaw J, et al. Economic impact of diabetes.IDF Diabetes Atlas. 4th ed. Brussels: International Diabetes Federation; 2010.

Fenwick E, Rees G, Pesudovs K, Dirani M, Kawasaki R, Wong TY, et al. Social and emotional impact of diabetic retinopathy: A review. Clin Experiment Ophthalmol. 2012;40:27–38.

Chua J,Lim CXY, Wong TY,Sabanayagam C, Diabetic retinopathy in Asia-pacific,Asia Pac J Ophthalmol (PHila),2018 Jan-Feb;7(1):3-16

Jayne E McComiskie, Panoptic versus conventional ophthalmoscope, Clinical and Experimental Ophthalmology 2004; 32: 238–242

I Tajunisah,H Nabilah, S C Reddy,Prevalence and Risk Factors for Diabetic Retinopathy-A study of 217 patients from University of Malaysia Medical Center. Med J Malaysia. 2006 October; 61(4).

I Tajunisah, PS Wong, LT Tan, et al, Awareness of eye complications and prevalence of retinopathy in the first visit to eye clinic among type 2 diabetic patients.Int J Ophthalmol.2014;4(5):519-524.

Maziah I, Ahmad N, Norashikin M et al, Study on Prevalence of Diabetic retinopathy at Health clinic setting (Klinik Kesihatan Cheneh, Kemaman). Proceedings of the scientific conference Jabatan Kesihatan Negeri Terengganu; 2009.

Kamilah K, Zamsurina A, Anita I, et al. A study of Diabetic Retinopathy on Diabetic Patient Attendings Fundus Camera at KK Hiliran, Proceedings of the Scientific Conference Jabatan Kesihatan Negeri Terengganu, 2009.

Keah SH, Chng KS. Prevalence of diabetic retinopathy in a primary care setting using digital retinal imaging technology. Malaysian Family Physician. 2006;1(1):19-22

National Diabetes Registry (NDR) Report 2020, Disease Control Division, Ministry of Health Malaysia.

Mallika PS, Lee PY, Cheah WL, Wong JS, Syed Alwi SAR, Nor Hayati H, Tan AK. Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East Malaysia. Malaysian Family Physician. 2011;6(2&3):60-65

Masliza H,Nani Draman, Wan M.I.W et al. Predictors of proliferative diabetic retinopathy among patients with Type 2 Diabetes Mellitus in Malaysia as detected by fundus photography. Journal of Taibah University Medical Sciences.2016;11 (4): 353-358

Ahmed RA, Khalil SN, Al-Qahtani MA. Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abh. Saudi Arabia. J Family Community Med. 2016;23(1):18–24.

Lima VC, Cavalieri GC, Lima MC, Nazario NO, Lima GC. Risk factors for diabetic retinopathy: a case-control study. Int J Retina Vitreous. 2016

National Institute for Clinical Excellence (NICE). Management of Type 2 diabetes. Retinopathy - screening and early management. London: NICE Inherited Clinical Guideline E. 2002.

Ministry of Health Malaysia (1997), Diabetes info series 1, Kuala Lumpur.

Hutchinson A. McIntosh A. Peters J. O’Keeffe C. et al. Effective of screening and monitoring tests for diabetic retinopathy-a systemic review. Diabetes UK.Diabetic Medicine 2000;17:495-506.

Harding SP, Broadbent DM, Neoh C, White MC,Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study, BMJ 1995;311:1131-5.

O’Hare JP, Hopper A, Madhaven C,Charny M, Purewal TS,Harney B,Griffiths J, Adding retinal photography to screening for diabeticretinopathy : a prospective study in primary care, BMJ 1996;312:679-82

Lopez-Bastida J,Cabrera-Lopez F,Serrano-Aguilar P, Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy, Diabetes UK, Diabetic Medicine, 2007;24:403-407.

Griffith SP, Freeman Wl, Shaw CJ, Mitchell WH,Olden CR,FIggs,LD. et al. Screening for diabetic retinopathy in clinical setting : A comparison of direct ophthalmoscopy by primary care physician with fundus photography, J Fam Pract 1993;37 (1) :49-56

Gill JM,Cole,DM,Lwbowits HM, Diamond JJ. Accuracy of Screening for Diabetic Retinopathy by Family Physicians. Ann Fam Med 2004;2(3):218-220.

McComiskie JE, Greer RM, Cole GA. Panoptic versus conventional ophthalmoscope, Clinical and experimental ophthalmology 2004;32:238-242.

Ministry of Health Malaysia (1999),Health Technology Assessment Report : Screening for Diabetic retinopathy, Health Technology Assessment Unit, Medical Development Division, Ministry of Health Malaysia, 1999.

Tan AK, Mallika PS, Aziz S, Asokumaran T, Intan G, Faridah HA. Comparison between the panoptic ophthalmoscope and the conventional direct ophthalmoscope in the detection of sight threatening diabetic retinopathy: the Kuching diabetic eye study. Malaysian Family Physician. 2010;5(2):83-90

Pejabat Kesihatan Daerah Seremban (2019), Rekod Beban Kerja Klinik Kesihatan Sendayan.

Klinik Kesihatan Sendayan (2019),Buku kedatangan pesakit Hypertensi dan Diabetes . Klinik Kesihatan Sendayan, 2019.

National Diabetic Registry Malaysia (2019) Number of Active cases in Klinik Kesihatan Sendayan. Diabetes Clinical Audit Registry.

Bujang MA, Adnan TH. Requirements for Minimum Sample Size for Sensitivity and Specificity Analysis. J Clin Diagn Res. 2016 Oct;10(10):YE01-YE06.

Kelsey et al.,Methods in Observational Epidemiology 2nd Edition, Table 12-15 Fleiss, Statistical Methods for Rates and Proportions, formulas 3.18 & 3.19https://www.openepi.com/SampleSize/SSCohort.htm

Tropicamide: Indication, Dosage, Side Effect, Precaution | MIMS.com Malaysia https://www.mims.com/malaysia/drug/info/tropicamide?mtype=generic

Garis panduan operasi fasiliti kesihatan primer pasca perintah kawalan pergerakan ,no 5. Rawatan pesakit Luar- Funduskopi menggunakan Fundus Camera, (Pindaan 1/2020), Bahagian PEmbanguna Kesihatan keluarga, Kementerian Kesihatan Malaysia,2020, p.12.




Copyright (c) 2021 Journal of Biomedical and Clinical Sciences (JBCS)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 

Flag Counter           

                     

                                              Copyright © 2016 AMDI Publisher, Universiti Sains Malaysia.
Disclaimer : This website has been updated to the best of our knowledge to be accurate. However, Universiti Sains Malaysia shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.
                                            Best viewed: Mozilla Firefox 4.0 & Google Chrome at 1024 × 768 resolution.